Zoledronic Acid for Breast Cancer-Induced Bone Loss: Incidence of Fractures and Cancer Recurrence

Feb 25, 2025

10 likes | 82 Views

Figure 1 displays pooled data from Z-FAST, ZO-FAST, and E-ZO-FAST studies, showing incidence rates of clinical fractures and breast cancer recurrence in patients receiving zoledronic acid therapy for breast cancer.

Share Presentation

Embed Code

nina-lawrence

Download Presentation

Zoledronic Acid for Breast Cancer-Induced Bone Loss: Incidence of Fractures and Cancer Recurrence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Figure 1 Forrest plot showing pooled data for a | incidence of clinical fractures and b | incidence of breast cancer recurrence from the Z‑FAST, ZO‑FAST and EZO‑FAST studies Eitan Amir, Alberto Ocaña, Bostjan Seruga, Robert Josse and Mark Clemons(2010)Zoledronic acid for breast cancer therapy-induced bone lossNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.19

nrclinonc.2012.61-pf2

Figure 2 Comparison of genome-wide gene-expression profiles between primary patient tumours and PDTX tumours. Tentler, J. J. et al. ( 2012) Patient-derived tumour xenografts as models for oncology drug development Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.61.

106 views • 1 slides

ncponc1183-pf1

Figure 1 Radiographic changes to melanoma metastases in the brain with administration of CTLA-4 blockade. Hodi FS et al . (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS Nat Clin Pract Oncol doi:10.1038/ncponc1183.

134 views • 1 slides

nrneph.2013.110-pf1

Figure 1 Mechanisms by which aldosterone and/or MR activation induce oxidative stress, inflammation, and fibrosis. Brown, N. J. (2013) Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis Nat. Rev. Nephrol. doi:10.1038/nrneph.2013.110.

164 views • 1 slides

nrclinonc.2010.37-pf1

Figure 1 Comparison of a | PFS and b | overall survival curves from the JGOG study on dosedense therapy 1 and the GOG study on IP therapy. Thomas Hogberg (2010) Current drugs still have potential in advanced ovarian cancer Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.37.

106 views • 1 slides

nrendo.2010.146-pf1

Figure 1 World map indicating developing countries as classified by World Bank criteria in color and relating latitude by geographic regions to skin ability to synthesize vitamin D as estimated from information provided in an article by Tavera-Mendoza and White.

127 views • 1 slides

nrurol.2009.235-pf1

Figure 1 Correlation between testosterone plasma levels and different clinical, instrumental and sexual parameters. Corona, C. & Maggi, M. (2009) The role of testosterone in erectile dysfunction Nat. Rev. Urol. doi:10.1038/nrurol.2009.235.

124 views • 1 slides

ncponc0379-pf1

Figure 1 Whole-body positron emission tomography scan showing a small glucose-avid lesion in the pelvis just superior to the bladder in the region of the left adnexa. Santillan A and Bristow RE (2006) Paraneoplastic cerebellar degeneration in a woman with ovarian cancer

127 views • 1 slides

nrneph.2009.67-pf1

Figure 1 Renal survival of patients in our study with pauci-immune crescentic glomerulonephritis with and without ANCAs. Permission obtained from the American Society of Nephrology  Chen, M. et al. Antineutrophil cytoplasmic autoantibody negative pauci-immune crescentic glomerulonephritis.

148 views • 1 slides

ncponc0294-pf1

Figure 1 CT scan of tumor progression showing enlarged right laterocervical lymph nodes (white arrows) and laryngeal tumor (black arrows). Ares C and Allal AS (2005) Long-term complete remission of laryngeal Kaposi's sarcoma after palliative

152 views • 1 slides

ncponc0044-pf1

Figure 1 The products of two genes are required to reconstitute basic telomerase activity; the RNA component, hTR, which includes the template for synthesis of telomere DNA, and the protein catalytic component, hTERT, which has reverse transcriptase activity.

157 views • 1 slides

ncpgasthep0096-pf1

FIGURE 1 Localization of potential relevant molecular targets in irritable bowel syndrome with the specific classes of agents discussed in this Review. Cremonini F and Talley NJ (2005) Treatments targeting putative mechanisms in irritable bowel syndrome

148 views • 1 slides

ncponc0135-pf1

Figure 1 Postpartum contrast-enhanced helical chest CT scan showing an enlarged internal mammary lymph node (white arrow). Matthew S Katz et al . (2005) Palpable right breast mass in a pregnant woman . Nat Clin Pract Oncol 2 : 218 – 221 10.1038/ncponc0135.

174 views • 1 slides

ncprheum0173-pf1

Figure 1 Minor salivary gland biopsy, stained with hematoxylin-eosin, from a patient with Sj ö gren's syndrome. Nordmark G et al. (2006) Mechanisms of Disease: primary Sj ö gren's syndrome and the type I interferon system Nat Clin Pract Rheumatol 2: 26 2 – 269 doi:10.1038/ ncprheum0173.

237 views • 1 slides

ncponc0813-pf1

Figure 1 Combination treatment schema for patients with rectal cancer enrolled in a clinical trial. Willett CG et al . (2007) Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer Nat Clin Pract Oncol 4 : 316 –321 doi:10.1038/ncponc0813.

151 views • 1 slides

ncponc1156-pf1

Figure 1 Results of cardiac function tests in the phase III trial of lapatinib plus capecitabine for metastatic breast cancer. Permission obtained from Geyer CE et al . (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355: 2733–2743.

116 views • 1 slides

ncponc0736-pf1

Figure 1 Schematic of oncolytic virotherapy mechanism of action: viral replication, cell killing, virus release and spread within cancer tissue but not normal tissues.

148 views • 1 slides

ncpneuro0658-pf1

Figure 1 Images of the case patient with an interstitial deletion of 5q22 encompassing the APC (adenomatous polyposis coli) gene, taken at 22 years of age. Heald B et al. (2007) Familial adenomatous polyposis in a patient with unexplained mental retardation

117 views • 1 slides

ncpneph0301-pf1

Figure 1 The principal source of renal dopamine is circulating L -DOPA, which is freely filtered by the glomerulus.

81 views • 1 slides

nrendo.2009.129 pf1

Figure 1 Statistical power of the DIAGRAM meta-analysis ( n = 9,562) to detect diabetes-related variants of different ORs across various risk allele frequencies, assuming complete coverage.

109 views • 1 slides

nrrheum.2014.167 pf1

Figure 1 Infection with JC virus is at first asymptomatic and presumably occurs at an early age by oral route. Calabrese, L. H. et al. (2014) Sorting out the risks in progressive multifocal leukoencephalopathy Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.167.

183 views • 1 slides

nrneurol.2014.178 pf1

Figure 1 Upstream determinants (genes and molecular pathology) and downstream effects (clinical phenotypes) for the main neurodegenerative disorders. Pievani, M. et al. (2014) Brain connectivity in neurodegenerative diseases—from phenotype to proteinopathy

126 views • 1 slides

nrendo.2014.185 pf1

Figure 1 Opposing association between lower-body fat accumulation and metabolically healthy obesity. Karpe, F. & Pinnick, K. E. (2014) Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes Nat. Rev. Endocrinol. doi:10.1038/nrendo.2014.185.

121 views • 1 slides

More Related